Daraprim
FDA approves first generic version of Shkreli-hiked toxoplasmosis drug Daraprim
March 2, 2020Sales and Marketing Cerovene, Daraprim, FDA, Martin Shkreli, generics, pharma
The FDA has awarded approval to the first generic medicine for the treatment of toxoplasmosis, authorising Cerovene’s version of Daraprim …
KaloBios cuts ties with former CEO Martin Shkreli, outlines ‘maniacal’ turnaround plan
August 30, 2016Research and Development, Sales and Marketing Daraprim, KaloBios, Martin Shkreli, Retrophin, benznidazole, turnaround
Two months after small drugmaker KaloBios returns from bankruptcy, controversial industry figure Martin Shkreli is no longer a stakeholder in …
Martin Shkreli subpoenaed in US to testify over drug pricing
January 21, 2016Medical Communications, Sales and Marketing Daraprim, Howard Schiller, Martin Shkreli, Valeant, turing
Former pharma chief exec Martin Shkreli has been issued with a subpoena by the US House of representatives, compelling him …
Karma may have caught up with Martin Shkreli, but America’s drug pricing problem isn’t about one man
December 18, 2015Manufacturing and Production, Sales and Marketing Daraprim, Martin Shkreli, Turing Pharmaceuticals
As so often occurs in situations of this kind, Twitter reacted with a significant amount of glee and schadenfreude to …
Turing chief exec Martin Shkreli arrested
December 17, 2015Medical Communications, Sales and Marketing Daraprim, FBI, Martin Shkreli, Shkreli, turing
Turing chief executive Martin Shkreli has been arrested on a charge of securities fraud relating to a company he founded, …
Imprimis launches low-cost Daraprim alternative
October 26, 2015Sales and Marketing Daraprim, Imprimis, Martin Skhreli, turing
Imprimis Pharmaceuticals has announced that it has made available a customisable compounded formulation of pyrimethamine and leucovorin accessible for physicians …
Turing faces antitrust probe over Daraprim price hike
October 14, 2015Sales and Marketing Daraprim, Turing Pharmaceuticals, turing
Turing Pharmaceuticals, the drug company that increased the price of the generic drug Daraprim 50-fold overnight, is facing an antitrust …
Turing will drop price of Daraprim following outrage
September 24, 2015Sales and Marketing Daraprim, Impax Laboratories, Martin Shkreli, Turing Pharmaceuticals, toxoplasmosis
Martin Shkreli, whose company Turing Pharmaceuticals increased the price of Daraprim more than fifty-fold overnight, has been forced to backpedal …
